# DNMT3A

## Overview
DNMT3A is a gene that encodes the enzyme DNA methyltransferase 3 alpha, a key player in the epigenetic regulation of gene expression through DNA methylation. As a member of the DNA methyltransferase family, DNMT3A is primarily involved in de novo methylation, establishing new methylation patterns during development and cellular differentiation. The protein contains several functional domains, including a catalytic C-terminal methyltransferase domain and histone reader modules, which facilitate its interaction with DNA and other proteins. DNMT3A's activity is crucial for maintaining genomic stability and regulating gene expression, impacting processes such as hematopoietic stem cell differentiation and gene silencing. Mutations in the DNMT3A gene are associated with various hematologic malignancies, including acute myeloid leukemia, and have significant clinical implications (Brunetti2016DNMT3A; Lyko2017The).

## Structure
The DNMT3A protein is a DNA methyltransferase involved in establishing DNA methylation patterns. Its primary structure consists of a sequence of amino acids that form several key domains. The protein contains a C-terminal methyltransferase (MTase) domain responsible for its catalytic activity, preceded by two histone reader modules: a proline-tryptophan-tryptophan-proline (PWWP) domain and an ATRX-DNMT3-DNMT3L-type (ADD) zinc finger domain (Lu2024Structureguided).

The secondary structure of DNMT3A includes alpha helices and beta sheets, which contribute to the formation of its catalytic domain and other functional regions. The tertiary structure of DNMT3A forms a catalytic domain that is crucial for its enzymatic function, and the PWWP domain is involved in DNA binding (Anteneh2020Structural).

DNMT3A can form a homotetramer or a heterotetramer with DNMT3L, representing its quaternary structure. This tetrameric assembly is essential for its function, as it facilitates DNA binding and methylation (Jia2007Structure). The RD interface is crucial for DNA binding, involving interactions with the target recognition domain (TRD) loop and catalytic loop (Anteneh2020Structural).

Post-translational modifications, such as phosphorylation, can regulate DNMT3A's activity. Splice variants of DNMT3A, including DNMT3A1 and DNMT3A2, exist and affect its function and localization, with DNMT3A1 being widely expressed in somatic cells and DNMT3A2 in germ cells and embryonic stem cells (Chen2024Structural).

## Function
DNMT3A is a DNA methyltransferase enzyme that plays a critical role in establishing DNA methylation patterns in human cells. It is primarily involved in de novo methylation, which is essential for the regulation of gene expression, genomic stability, and cellular differentiation (Lyko2017The). DNMT3A methylates the C-5 position of cytosine within CpG dinucleotides, affecting a significant portion of the genome (Gao2020Comprehensive). This methylation process is crucial for transcriptional silencing, particularly in the context of hematopoietic stem cells (HSCs), where DNMT3A facilitates differentiation by repressing stem cell-specific genes (Challen2011Dnmt3a).

In addition to its role in gene silencing, DNMT3A is involved in the methylation of gene bodies, which correlates with gene transcription and may help restrict the activation of cryptic promoters within transcribed genes (Lyko2017The). DNMT3A's activity is regulated by interactions with other proteins, such as DNMT3L, which enhances its DNA binding affinity and methylation efficiency (Lyko2017The). The enzyme is active in the nucleus, where it contributes to the maintenance and dynamic remodeling of DNA methylation patterns, ensuring proper gene expression and cellular function (Lyko2017The).

## Clinical Significance
Mutations in the DNMT3A gene are significantly associated with various hematologic malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). In AML, DNMT3A mutations, especially at the R882 codon, are prevalent and linked to poor prognosis and adverse clinical outcomes. These mutations are often found in patients with intermediate-risk cytogenetic profiles and are associated with a higher risk of relapse and shorter overall survival (Brunetti2016DNMT3A; Shah2011DNMT3A). DNMT3A mutations are also implicated in clonal hematopoiesis, which can lead to an increased risk of developing hematologic cancers and other health issues, such as cardiovascular diseases (Brunetti2016DNMT3A).

In MDS, DNMT3A mutations are present in a subset of patients and are associated with a more rapid progression to AML, indicating their prognostic value (Walter2011Recurrent). These mutations are considered early events in cancer development, providing a self-renewal advantage to hematopoietic stem cells, which contributes to clonal expansion and disease progression (Yang2015DNMT3A).

DNMT3A mutations are also linked to Tatton-Brown-Rahman syndrome, characterized by tall stature, distinctive facial appearance, and intellectual disability (Brunetti2016DNMT3A). The gene's role in DNA methylation and its interaction with histone modifications are crucial in understanding its impact on these diseases (Brunetti2016DNMT3A).

## Interactions
DNMT3A, a DNA methyltransferase, engages in various protein-protein interactions crucial for its function in epigenetic regulation. It forms a complex with DNA methyltransferase 3-like protein (DNMT3L), which enhances its enzymatic activity by stabilizing the active-site loop of DNMT3A. This interaction is essential for de novo DNA methylation, particularly in the context of imprinted genes in mammalian germ cells (Jia2007Structure).

DNMT3A also interacts with components of the polycomb repressive complex 1 (PRC1), such as RING1B and Bmi1. These interactions are particularly significant in the context of the R882 mutation, which enhances DNMT3A's affinity for PRC1 components, leading to the silencing of differentiation-associated genes in hematopoietic stem cells and leukemic cells. This interaction is independent of DNMT3A's traditional role in DNA methylation and contributes to leukemogenesis (Koya2016DNMT3A).

Additionally, DNMT3A interacts with the MPP8 chromodomain and the GLP/G9a complex, linking DNA methylation with histone H3K9 methylation. This interaction is mediated by the methylation of DNMT3A's lysine residue, which is recognized by MPP8, forming a silencing complex on chromatin templates (Chang2011MPP8).


## References


[1. (Lu2024Structureguided) Jiuwei Lu, Yiran Guo, Jiekai Yin, Jianbin Chen, Yinsheng Wang, Gang Greg Wang, and Jikui Song. Structure-guided functional suppression of aml-associated dnmt3a hotspot mutations. Nature Communications, April 2024. URL: http://dx.doi.org/10.1038/s41467-024-47398-y, doi:10.1038/s41467-024-47398-y. This article has 3 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-47398-y)

[2. (Challen2011Dnmt3a) Grant A Challen, Deqiang Sun, Mira Jeong, Min Luo, Jaroslav Jelinek, Jonathan S Berg, Christoph Bock, Aparna Vasanthakumar, Hongcang Gu, Yuanxin Xi, Shoudan Liang, Yue Lu, Gretchen J Darlington, Alexander Meissner, Jean-Pierre J Issa, Lucy A Godley, Wei Li, and Margaret A Goodell. Dnmt3a is essential for hematopoietic stem cell differentiation. Nature Genetics, 44(1):23–31, December 2011. URL: http://dx.doi.org/10.1038/ng.1009, doi:10.1038/ng.1009. This article has 862 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.1009)

[3. (Anteneh2020Structural) Hiwot Anteneh, Jian Fang, and Jikui Song. Structural basis for impairment of dna methylation by the dnmt3a r882h mutation. Nature Communications, May 2020. URL: http://dx.doi.org/10.1038/s41467-020-16213-9, doi:10.1038/s41467-020-16213-9. This article has 50 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-16213-9)

[4. (Brunetti2016DNMT3A) Lorenzo Brunetti, Michael C. Gundry, and Margaret A. Goodell. Dnmt3a in leukemia. Cold Spring Harbor Perspectives in Medicine, 7(2):a030320, December 2016. URL: http://dx.doi.org/10.1101/cshperspect.a030320, doi:10.1101/cshperspect.a030320. This article has 140 citations and is from a peer-reviewed journal.](https://doi.org/10.1101/cshperspect.a030320)

[5. (Shah2011DNMT3A) Mrinal Y Shah and Jonathan D Licht. Dnmt3a mutations in acute myeloid leukemia. Nature Genetics, 43(4):289–290, March 2011. URL: http://dx.doi.org/10.1038/ng0411-289, doi:10.1038/ng0411-289. This article has 46 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng0411-289)

[6. (Yang2015DNMT3A) Liubin Yang, Rachel Rau, and Margaret A. Goodell. Dnmt3a in haematological malignancies. Nature Reviews Cancer, 15(3):152–165, February 2015. URL: http://dx.doi.org/10.1038/nrc3895, doi:10.1038/nrc3895. This article has 366 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrc3895)

[7. (Gao2020Comprehensive) Linfeng Gao, Max Emperle, Yiran Guo, Sara A. Grimm, Wendan Ren, Sabrina Adam, Hidetaka Uryu, Zhi-Min Zhang, Dongliang Chen, Jiekai Yin, Michael Dukatz, Hiwot Anteneh, Renata Z. Jurkowska, Jiuwei Lu, Yinsheng Wang, Pavel Bashtrykov, Paul A. Wade, Gang Greg Wang, Albert Jeltsch, and Jikui Song. Comprehensive structure-function characterization of dnmt3b and dnmt3a reveals distinctive de novo dna methylation mechanisms. Nature Communications, July 2020. URL: http://dx.doi.org/10.1038/s41467-020-17109-4, doi:10.1038/s41467-020-17109-4. This article has 132 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-17109-4)

[8. (Walter2011Recurrent) M J Walter, L Ding, D Shen, J Shao, M Grillot, M McLellan, R Fulton, H Schmidt, J Kalicki-Veizer, M O’Laughlin, C Kandoth, J Baty, P Westervelt, J F DiPersio, E R Mardis, R K Wilson, T J Ley, and T A Graubert. Recurrent dnmt3a mutations in patients with myelodysplastic syndromes. Leukemia, 25(7):1153–1158, March 2011. URL: http://dx.doi.org/10.1038/leu.2011.44, doi:10.1038/leu.2011.44. This article has 434 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/leu.2011.44)

[9. (Koya2016DNMT3A) Junji Koya, Keisuke Kataoka, Tomohiko Sato, Masashige Bando, Yuki Kato, Takako Tsuruta-Kishino, Hiroshi Kobayashi, Kensuke Narukawa, Hiroyuki Miyoshi, Katsuhiko Shirahige, and Mineo Kurokawa. Dnmt3a r882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nature Communications, March 2016. URL: http://dx.doi.org/10.1038/ncomms10924, doi:10.1038/ncomms10924. This article has 66 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms10924)

[10. (Chang2011MPP8) Yanqi Chang, Lidong Sun, Kenji Kokura, John R. Horton, Mikiko Fukuda, Alexsandra Espejo, Victoria Izumi, John M. Koomen, Mark T. Bedford, Xing Zhang, Yoichi Shinkai, Jia Fang, and Xiaodong Cheng. Mpp8 mediates the interactions between dna methyltransferase dnmt3a and h3k9 methyltransferase glp/g9a. Nature Communications, November 2011. URL: http://dx.doi.org/10.1038/ncomms1549, doi:10.1038/ncomms1549. This article has 128 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms1549)

[11. (Chen2024Structural) Xinyi Chen, Yiran Guo, Ting Zhao, Jiuwei Lu, Jian Fang, Yinsheng Wang, Gang Greg Wang, and Jikui Song. Structural basis for the h2ak119ub1-specific dnmt3a-nucleosome interaction. Nature Communications, July 2024. URL: http://dx.doi.org/10.1038/s41467-024-50526-3, doi:10.1038/s41467-024-50526-3. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-50526-3)

[12. (Lyko2017The) Frank Lyko. The dna methyltransferase family: a versatile toolkit for epigenetic regulation. Nature Reviews Genetics, 19(2):81–92, October 2017. URL: http://dx.doi.org/10.1038/nrg.2017.80, doi:10.1038/nrg.2017.80. This article has 902 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrg.2017.80)

[13. (Jia2007Structure) Da Jia, Renata Z. Jurkowska, Xing Zhang, Albert Jeltsch, and Xiaodong Cheng. Structure of dnmt3a bound to dnmt3l suggests a model for de novo dna methylation. Nature, 449(7159):248–251, August 2007. URL: http://dx.doi.org/10.1038/nature06146, doi:10.1038/nature06146. This article has 650 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature06146)